Related Experiment Video
Updated: Aug 9, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Global review of multidrug therapy (MDT) in leprosy
S K Noordeen1, L Lopez Bravo, D Daumerie
1Leprosy Unit, World Health Organization, Geneva.
Abstract:
Leprosy continues to be an important public health problem in most countries of Asia, Africa and Latin America. While there has been a steady increase in the number of registered leprosy cases from 1966 to 1985, since then there has been a substantial reduction of over 30% in the number of registered cases. This is mainly attributed to the introduction of multidrug therapy (MDT) as recommended by a WHO study group on chemotherapy of leprosy for control programmes in 1981. The coverage for MDT has steadily increased over the last 5 years, reaching a global figure of 55.7% of all registered cases by October 1990. Over 2 million leprosy patients are currently undergoing MDT and, in addition, over 1 million patients have completed MDT since 1985. MDT has been found to be generally well tolerated with a high level of acceptability leading to improved treatment compliance. MDT coverage shows wide variations among WHO regions and among individual countries. The prospects for further reductions in prevalence of registered cases in the next decade are very bright. However, problems such as early case detection, and prevention and management of disabilities after patients have been curred for several years, will continue to pose significant challenges.
Insights
Multidrug therapy (MDT) has significantly reduced leprosy cases by over 30% globally since 1985. High treatment compliance and widespread MDT coverage offer bright prospects for further leprosy prevalence reduction.
Area of Science:
- Public Health
- Infectious Diseases
- Tropical Medicine
Background:
- Leprosy remains a significant global public health issue, particularly in Asia, Africa, and Latin America.
- Historically, leprosy case numbers increased until 1985, posing a substantial disease burden.
Purpose of the Study:
- To evaluate the impact of multidrug therapy (MDT) on global leprosy prevalence.
- To assess the current status and future prospects of leprosy control programs.
Main Methods:
- Analysis of registered leprosy case data from 1966 to 1990.
- Review of multidrug therapy (MDT) coverage and patient treatment completion rates.
- Assessment of treatment compliance and tolerability of MDT.
Main Results:
- A reduction of over 30% in registered leprosy cases since 1985, attributed to MDT.
- Global MDT coverage reached 55.7% by October 1990, with over 2 million patients undergoing treatment and 1 million completing it.
- MDT demonstrated good tolerability and high acceptability, leading to improved patient compliance.
Conclusions:
- MDT has been highly effective in reducing leprosy prevalence, with strong prospects for further decreases.
- Challenges remain in early case detection and managing long-term disabilities in leprosy patients.
- Addressing regional variations in MDT coverage is crucial for global leprosy control efforts.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors
Clinical Significance of Antibiotic Resistance
Antiprotozoal Agents

